PROGNOSTIC-SIGNIFICANCE OF ORAL LESIONS IN CHILDREN WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

被引:51
|
作者
KATZ, MH
MASTRUCCI, MT
LEGGOTT, PJ
WESTENHOUSE, J
GREENSPAN, JS
SCOTT, GB
机构
[1] DEPT PUBL HLTH,SAN FRANCISCO,CA
[2] UNIV MIAMI,DEPT PEDIAT,CORAL GABLES,FL 33124
[3] UNIV BRITISH COLUMBIA,DEPT CLIN DENT SCI,VANCOUVER V6T 1W5,BC,CANADA
来源
关键词
D O I
10.1001/archpedi.1993.02160250047015
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective.-To assess the prevalence and prognostic significance of oral lesions in children with human immunodeficiency virus infection. Design.-Clinical cohort study. Setting.-Children's Hospital Center at Jackson Memorial Hospital, Miami, Fla. Participants.-Ninety-nine children with perinatally acquired human immunodeficiency virus infection examined longitudinally for oral lesions. Interventions.-None. Measurements/Main Results.-Presence of oral lesions was determined by a pediatrician who had been trained in the diagnosis of oral lesions. The cumulative prevalence of lesions was 72% for oral candidiasis, 47% for parotid enlargement, and 24% for herpes simplex. The median time from birth to development of a lesion was 2.4 years for candidiasis, 4.6 years for parotid enlargement, and 5 years for herpes simplex. The median time from lesion to death was 3.4 years for patients with candidiasis, 5.4 years for patients with parotid enlargement, and 4.3 years for patients with herpes simplex. In a time-dependent proportional-hazards model, oral candidiasis was associated with a more rapid rate of progression to death (relative hazard, 14.2; 95% confidence interval, 4.8 to 41.8), while parotid enlargement was associated with a less rapid rate of progression to death (relative hazard, 0.38; 95% confidence interval, 0.16 to 0.88) and herpes simplex was unrelated to the rate of progression (relative hazard, 1.3; 95% confidence interval, 0.5 to 3.1). Conclusions.-The presence of oral candidiasis and parotid enlargement confer important prognostic information and should be incorporated into decisions regarding therapy for HIV-infected children.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
  • [1] Oral lesions in children with perinatally acquired human immunodeficiency virus infection
    Nicolatou, O
    Theodoridou, M
    Mostrou, G
    Velegraki, A
    Legakis, NJ
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1999, 28 (02) : 49 - 53
  • [2] VARICELLA IN CHILDREN WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    KELLEY, R
    MANCAO, M
    LEE, F
    SAWYER, M
    NAHMIAS, A
    NESHEIM, S
    [J]. JOURNAL OF PEDIATRICS, 1994, 124 (02): : 271 - 273
  • [3] ENCEPHALOPATHY IN CHILDREN WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    LOBATO, MN
    CALDWELL, MB
    NG, P
    OXTOBY, MJ
    [J]. JOURNAL OF PEDIATRICS, 1995, 126 (05): : 710 - 715
  • [4] PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    OXTOBY, MJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (09) : 609 - 619
  • [5] PROGNOSTIC-SIGNIFICANCE OF IMMUNOLOGICAL CHANGES IN 675 INFANTS PERINATALLY EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS
    DEMARTINO, M
    TOVO, PA
    GALLI, L
    GABIANO, C
    COZZANI, S
    GOTTA, C
    SCARLATTI, G
    FIOCCHI, A
    COCCHI, P
    MARCHISIO, P
    CANINO, R
    MAUTONE, A
    CHIAPPE, F
    CAMPELLI, A
    CONSOLINI, R
    IZZI, G
    LAVERDA, A
    ALBERTI, S
    TOZZI, AE
    DUSE, M
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (05): : 702 - 709
  • [6] OLDER CHILDREN AND ADOLESCENTS LIVING WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    GRUBMAN, S
    GROSS, E
    LERNERWEISS, N
    HERNANDEZ, M
    MCSHERRY, GD
    HOYT, LG
    BOLAND, M
    OLESKE, JM
    [J]. PEDIATRICS, 1995, 95 (05) : 657 - 663
  • [7] PRESENCE AND PROGNOSTIC-SIGNIFICANCE OF ANTILYMPHOCYTE ANTIBODIES IN SYMPTOMATIC AND ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    DORSETT, BH
    CRONIN, W
    IOACHIM, HL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (05) : 1025 - 1028
  • [8] THYROID-FUNCTION IN CHILDREN WITH PERINATALLY ACQUIRED ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS
    BLETHEN, SL
    NACHMAN, S
    CHASALOW, FI
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 1994, 7 (03) : 201 - 204
  • [9] HOW LONG MAY PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION LAST ASYMPTOMATICALLY
    MANFREDI, R
    RAGAZZINI, I
    ZUCCHINI, A
    DIFIORE, MT
    MANFREDI, G
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (09) : 821 - 822
  • [10] EFFECT OF PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON NEURODEVELOPMENT IN CHILDREN DURING THE FIRST 2 YEARS OF LIFE
    NOZYCE, M
    HITTELMAN, J
    MUENZ, L
    DURAKO, SJ
    FISCHER, ML
    WILLOUGHBY, A
    [J]. PEDIATRICS, 1994, 94 (06) : 883 - 891